ATE128237T1 - Test für hepatitis-c. - Google Patents

Test für hepatitis-c.

Info

Publication number
ATE128237T1
ATE128237T1 AT90125354T AT90125354T ATE128237T1 AT E128237 T1 ATE128237 T1 AT E128237T1 AT 90125354 T AT90125354 T AT 90125354T AT 90125354 T AT90125354 T AT 90125354T AT E128237 T1 ATE128237 T1 AT E128237T1
Authority
AT
Austria
Prior art keywords
assay
sample
hepatitis
test
hcv antigen
Prior art date
Application number
AT90125354T
Other languages
English (en)
Inventor
Tat Leung
James M Casey
Virender Kumar Sarin
Smriti U Mehta
Sushil G Devare
Richard R Lesniewski
Suresh M Desai
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE128237T1 publication Critical patent/ATE128237T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
    • C07K16/118—Hepatitis C virus; GB virus C [GBV-C]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT90125354T 1989-12-22 1990-12-22 Test für hepatitis-c. ATE128237T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45616289A 1989-12-22 1989-12-22
US61018090A 1990-11-07 1990-11-07

Publications (1)

Publication Number Publication Date
ATE128237T1 true ATE128237T1 (de) 1995-10-15

Family

ID=27038137

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90125354T ATE128237T1 (de) 1989-12-22 1990-12-22 Test für hepatitis-c.

Country Status (7)

Country Link
EP (1) EP0445423B1 (de)
JP (1) JP3188717B2 (de)
AT (1) ATE128237T1 (de)
AU (1) AU638304B2 (de)
CA (1) CA2032907C (de)
DE (1) DE69022578T2 (de)
ES (1) ES2080099T3 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
CA2017157C (en) * 1989-05-18 2003-07-29 Michael Houghton Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
US5308750A (en) * 1989-12-22 1994-05-03 Abbott Laboratories Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
WO1991015771A1 (en) † 1990-04-04 1991-10-17 Chiron Corporation Combinations of hepatitis c virus (hcv) antigens for use in immunoassays for anti-hcv antibodies
ATE194844T1 (de) * 1990-04-06 2000-08-15 Genelabs Tech Inc Hepatitis c-virus-epitope
CA2049679C (en) * 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
DK0484787T3 (da) * 1990-11-03 2002-02-04 Dade Behring Marburg Gmbh HCV-specifikke peptider, fremgangsmåde til opnåelse deraf og anvendelse deraf
EP0485209A1 (de) * 1990-11-08 1992-05-13 Immuno Japan Inc. Mit Non-A Non-B Hepatitis Virus verwandtes Antigen, Aufspürsysteme für Antikörper, Polynukleotide und Polypeptide
EP0516859A1 (de) * 1990-11-29 1992-12-09 Toray Industries, Inc. Non-a non-b hepatitisvirus-antigenprotein
US6007982A (en) * 1990-12-14 1999-12-28 Innogenetics N.V. Synthetic antigens for the detection of antibodies to hepatitis C virus
ATE185350T1 (de) * 1990-12-14 1999-10-15 Innogenetics Nv Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus
US5910404A (en) * 1990-12-14 1999-06-08 Innogenetics N.V. Synthetic antigens for the detection of antibodies to hepatitis C virus
AU1459792A (en) * 1991-01-14 1992-08-27 James N. Gamble Institute Of Medical Research Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
DK0569537T3 (da) * 1991-01-31 1999-04-06 Abbott Lab Monoklonale antistoffer mod formodede HCV-kapperegioner og fremgangsmåder til anvendelse deraf
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
HU227547B1 (en) * 1991-06-24 2011-08-29 Novartis Vaccines & Diagnostic Hepatitis c virus (hcv) polypeptides
WO1993004084A1 (en) * 1991-08-21 1993-03-04 Abbott Laboratories Monoclonal antibodies to putative hcv ns5 proteins and methos for using same
CA2119013A1 (en) * 1991-09-16 1993-04-01 Richard R. Lesniewski Hepatitis c assay
DE610436T1 (de) * 1991-11-21 1995-08-03 Common Services Agency Detektion des Hepatis-C Virus.
JPH05176773A (ja) * 1991-12-27 1993-07-20 Imuno Japan:Kk オリゴヌクレオチド、オリゴペプタイド、ならびに抗ｃ型肝 炎ウイルス抗体検出・鑑別方法
GB9203803D0 (en) * 1992-02-21 1992-04-08 Wellcome Found A recombinant polypeptide
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
RU2104284C1 (ru) * 1994-10-20 1998-02-10 Научно-исследовательский институт вирусологии им.Д.И.Ивановского РАМН Синтетические олигопептиды, специфически взаимодействующие с антителами к вирусу гепатита с, способы диагностики hcv-инфекции (варианты)
GB2294690B (en) * 1994-11-01 1998-10-28 United Biomedical Inc Peptides effective for diagnosis and detection of hepatitis C infection
DE19504302A1 (de) * 1995-02-09 1996-08-14 Boehringer Mannheim Gmbh Methode zur serologischen Typisierung mittels typspezifischer Antigene
DE19540105C1 (de) * 1995-09-19 1997-02-20 United Biomedical Inc Peptidzusammensetzungen zur Diagnose und zum Nachweis von Hepatitis C Virus (HCV)-Infektion
CA2305847A1 (en) 1997-11-06 1999-05-20 Innogenetics N.V. Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318216B2 (de) * 1987-11-18 2001-08-29 Chiron Corporation NANBV-Diagnostika
KR0185373B1 (ko) * 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용

Also Published As

Publication number Publication date
DE69022578D1 (de) 1995-10-26
CA2032907C (en) 2002-05-14
DE69022578T2 (de) 1996-05-02
EP0445423A2 (de) 1991-09-11
AU6839090A (en) 1991-06-27
CA2032907A1 (en) 1991-06-23
EP0445423A3 (en) 1992-04-29
EP0445423B1 (de) 1995-09-20
ES2080099T3 (es) 1996-02-01
JPH04253998A (ja) 1992-09-09
AU638304B2 (en) 1993-06-24
JP3188717B2 (ja) 2001-07-16

Similar Documents

Publication Publication Date Title
ATE128237T1 (de) Test für hepatitis-c.
ES2082777T3 (es) Un metodo para la deteccion de un anti-cuerpo y antigeno en un inmunoensayo.
EP0375422A3 (de) Zusammensetzung und Methoden zur Bestimmung der Anwesenheit von Amphetaminen in einer Probe, die in Verdacht steht, Amphetamine und/oder Metamphetamine zu enthalten
ES2148225T3 (es) Reactivos y procedimientos que permiten la deteccion y la cuantificacion de la tiroxina en muestras de fluido.
DE3579841D1 (de) Multisites immunometrisches testverfahren.
TW222686B (de)
DE69025940D1 (de) Durch Silber intensiviertes, auf Goldmarkierung beruhendes Immuntestverfahren
ES2139571T3 (es) Ensayo de hepatitis c que utiliza antigenos recombinantes.
ATE254286T1 (de) Zwei-inkubations mit markiertem antigen verwendenes immunoassay
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
NO874140L (no) Immunometriske bestemmelsesfremgangsmaater.
ATE67603T1 (de) Zusammensetzungen zum immunoenzymatischen test von prostaglandinen.
EP0245052A3 (de) Feststellung einer Entzündung und Antikörper dazu
ATE182172T1 (de) Immunologischer nachweis von metolachlor
DE3679926D1 (de) Nachweis von human-t-zellen-leukemievirus des typs-iii.
ATE180282T1 (de) Antikörpertest zur erkennung von alkoholikern und zur überwachung der alkoholaufnahme
NO175024C (no) Agglutineringsreagens og dets anvendelse for detektering av et antigen, antistoffer eller andre analytter, samt prövesett omfattende reagensen
DE68919521D1 (de) Immuntest zum Nachweis von alpha-Haloacetamiden.
DE58907725D1 (de) Mittel für immunchemische Tests enthaltend Aminoxide.
IT1237809B (it) Metodo per la determinazione qualitativa e quantitativa di anticorpi diretti contro antigeni batterici attraverso la misurazione fotometrica dell'agglutinazione.
DE60018785D1 (de) Immunoassay von c-peptid-enthaltenden verunreinigungen in rekombinantem human-insulin
ES2016992B3 (es) Reagente y procedimiento en la determinacion c 3a mediante ensayo inmunoquimico.
KR850003169A (ko) 염기성 태아단백질의 측정방법 및 시약
ATE208041T1 (de) A-protein als diagnostikum für krebs
ES2066973T3 (es) Inmunoanalisis de elastasa-1.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee